Proven Vct Regulatory News (PVN)

9 Jul 2007 11:45

Oasis Healthcare PLC09 July 2007 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached Oasis Healthcare plc 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights (x) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached ( ) An event changing the breakdown of voting rights ( ) Other (specify): 3. Full name of person(s) subject to the notification obligation: Proven VCT Plc 4. Full name of shareholder(s) (if different from 3.) N/A 5. Date of the transaction (and date on which the threshold is crossed orreached if different): 5 July 2007 6. Date on which issuer notified: 9 July 2007 7. Threshold(s) that is/are crossed or reached: Now have a 0% holding 8. Notified details: A. Voting rights attached to shares Class/type of shares (if possible using the ISIN code) Ordinary Shares GB0006556152 Situation previous to the Resulting situation after the triggering transaction triggering transactionNumber of Number of Number of Number of voting rights % of voting rights Voting Rights sharesShares Direct Direct Indirect Direct Indirect 2,212,481 2,212,481 - - - - - Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration date Exercise/ Conversion Number of voting % of voting rightsinstrument Period/Date rights that may be acquired if the instrument is exercised/ converted - - - - - Total (A+B) Number of voting rights % of voting rights - 0% 9. Chain of controlled undertakings through which the voting rights and/ or the financial instruments are effectively held, if applicable: - Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: N/A 14: Contact name: N/A 15. Contact telephone number: N/A This information is provided by RNS The company news service from the London Stock Exchange